Aerobic capacity testing with inactive individuals: the role of subjective experience

J Phys Act Health. 2013 Feb;10(2):271-9. doi: 10.1123/jpah.10.2.271. Epub 2012 Feb 29.

Abstract

Background: Maximal oxygen uptake (VO2max), an assessment of cardiorespiratory fitness, is regularly used as the primary outcome in exercise interventions. Many criteria have been suggested for validating such tests-most commonly, a plateau in oxygen consumption. The current study investigated the proportion of inactive individuals who reached a plateau in oxygen uptake and who achieved a valid test as assessed by secondary criteria (RERmax ≥ 1.1; RPEmax ≥ 18; age predicted HRmax ±10bpm), and the correlates of a successful plateau or achievement of secondary criteria during a VO2max session.

Methods: Participants (n = 240) were inactive individuals who completed VO2max assessments using an incremental treadmill test. We explored physical, behavioral, and motivational factors as predictors of meeting criteria for meeting a valid test.

Results: Approximately 59% of the sample achieved plateau using absolute (increase of VO2 of 150ml O2 or less) and 37% achieved plateau using relative (increase of VO2 of 1.5ml/kg O2 or less) criteria. Being male, having a higher BMI, a greater waist-to-hip ratio, and increased self-efficacy were associated with lower odds of achieving an absolute plateau, whereas none of these factors predicted odds of achieving relative plateau.

Conclusion: Findings raise questions about the validity of commonly used criteria with less active populations.

Trial registration: ClinicalTrials.gov NCT01091857.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Body Mass Index
  • Body Weights and Measures
  • Exercise / physiology*
  • Exercise / psychology
  • Exercise Test
  • Female
  • Health Behavior*
  • Humans
  • Male
  • Middle Aged
  • Motivation*
  • Oxygen Consumption / physiology*
  • Sedentary Behavior*
  • Self Efficacy
  • Young Adult

Associated data

  • ClinicalTrials.gov/NCT01091857